It has been known that gynecomastia is often associated with numerous clinical conditions, i. e., normal puberty, hypergonadotropic hypogonadism, tumors of the testis, disorders of sex, bronchogenic carcinoma, adrenocortical carcinoma, diseases of the thyroid gland and pituitary, diseases of the liver, malnutrition, after the period of sexual decline (Wallach et al., 1957; Treves, 1958; Hall, 1960; Kessel et al., 1963) . But the etiology of gynecomastia seems to remain obscure.
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The histological approaches made so far in clarifying the mechanism of gynecomastia appear to be unsuccessful, because microscopically gynecomastia shows similar findings of ductal hyperplasia and an increase in collagenous fibres in all cases of various clinical conditions.
An attempt was made with a newly devised chromatographic system to estimate individual estrogens, 17-ketosteroids and 17-hydroxycorticosteroids present in the urine of normal subjects and patients with bilateral gynecomastia in order to make an etiological pursuance of the disease. As a result it was generally found that there were certain differences in the patterns of urinary estrogens and/or 17-ketosteroids between a normal and a diseased group.
MATERIALS AND METHODS

Material
Twenty one cases of gynecomastia and 20 cases of mastopathia admitted to the university hospital were studied. Cases with a unilateral breast enlargement were excluded from the present study so that the elimination of breast tumor cases might be assured. As controls, 24 normal males (25-50 years old), 6 male cases of arrested tuberculosis (20-35 years old) and 10 normal females of luteal phase were studied. These controls were selected at random. Quantitative determination of estrogens The technique used in this study involved acid hydrolysis of 200ml of urine, extraction with ether containing toluene, separation of the phenolic fraction from the neutral fraction, purification of the phenolic fraction by the method of Bauld (1956) , separation of individual estrogens by elution chromatography on partially esterified Amberlite IRC-50 using a mixture of ethanol and water (3:2 by vol.) as the eluant, and fluorometric estimation (Matsumoto and Seki, 1963a and b.) Chromatographic separation of the individual 17-ketosteroids and 17-hydroxycorticosteroids present in the residues described above was performed by elution chromatography on partially esterified Amberlite IRC-50 using a mixture of ethanol, methanol and water (9:3:8 by vol.) as the eluant (Seki and Matsumoto, 1963) . The 17-ketosteroids and 17-hydroxycorticosteroids present in the effluent fractions were determined photometrically by the Zimmermann reaction and the Porter-Silber reaction.
The separation of individual 17-hydroxycorticosteroids was not satisfactory ( Fig. 1 ), e.g., tetrahydrocortisol, tetrahydrocortisone and cortisol were eluted together into the same fractions and allotetrahydrocortisol overlapped with cortisone. A search for optimal conditions for successful separation of these steroids is under way.
RESULTS
AND DISCUSSION
Urinary 17-ketosteroids and estrogens in cases of gynecomastia and normal males were quantitatively determined ( Table 1) . None of the cases examined showed abnormalities of liver function on routine tests. A mean value of total urinary 17-hydroxycorticosteroids in cases of gynecomastia was somewhat lower than that of normal males, although it was within a normal range.
No remarkable findings were obtained from the present analytical data of 17-hydroxycorticosteroids, e.g., the ratio of tetrahydrocortisol plus tetrahydrocortisone plus hydrocortisone to allotetrahydrocortisol plus cortisone was within a normal range. It is to be noted that there were differences observed between normal males Fishman, 1963) . Therefore it seems impossible to evaluate a possible contribution of metabolic pathways which have been suggested by Fishman (1963) , to the inactivation of estrogens in type A or C gynecomastia.
17-Ketosteroids
The excretion of 17-ketosteroids of 24 normal males and 6 male cases with arrested minimal tuberculosis (Figs. 6 and 7) showed the following characteristics:
varied from 3 to 10, and (2) the ratio of etiocholanolone to androsterone varied from 0.5 to 2. Since etiocholanolone and androsterone are formed by the steroids secreted from both adrenals and gonads, and 11-oxygenated 17-ketosteroids by the steroids secreted from adrenals, the ratio of the amounts of the former two steroids to the latter may indicate a relative dominance of activity between the gonads and the adrenals. Such indication may be justifi ed from the observation that the ratio decreased following castration, although Mande Wiele et al. (1962) reported that etiocholanolone and androsterone were mostly derived from de- hydroepiandrosterone, a steroid secreted from the adrenals. The meaning of the ratio of etiocholanolone to androsterone seems to have been leftunclarified, although it is suggested that the ratio may be adopted as a kind of measure for the inactivation of androgens.
It is a significant finding that the ratio of etiocholanolone plus androsterone to 11-oxygenated 17-ketosteroids was less than 3 in 10 cases out of the 17 cases of gynecomastia studied (Fig. 8) . A typical elution pattern of neutral fraction of 17-ketosteroids was below a normal range in half the cases of gynecomastia studied.
In 2 out of the 17 cases, the amount of etiocholanolone excreted was 3 to 5 times larger than that of androsterone (Fig. 9) . Thus, an increased inactivation of androgens and/or a decreased rate of secretion of testicular androgens and dehydroepiandrosterone seem to constitute a causal factor in some cases of gynecomastia. It is generally accepted that the priming with estrogen is necessary for trophic hormone such as ACTH, growth hormone, prolactin and gonadotrophin to promote the development of gynecomastia. Therefore, it is suggested that an abnormal secretion and/or disturbed metabolism of estrogens and androgens might be a primary causative factor for many cases of bilateral gynecomastia. In 10 out of 17 cases of gynecomastia, the ratio of etiocholanolone plus androsterone to 11-oxygenated 17-ketosteroids was less than 3. A normal value of the ratio varied from 3 to 10. The ratio of etiocholanolone to androsterone was more than 3 in 2 cases. A normal value ranged from 0.5 to 2. A total amount of 17-ketosteroids was less than a normal range in half the cases of gynecomastia studied.
Thus, in some cases of gynecomastia, it is suggested that breast stimulation is brought about by an increased secretion and/or a decreased rate of inactivation of estrogens, and a decreased secretion of gonadal androgens and/or dehydroepiandrosterone may enhance the action of estrogens on mammary tissues.
